← Back to headlines
FDA Panel Narrowly Backs Four Peptides
An FDA panel has narrowly voted to back four peptides, bringing the stock of companies like Hims & Hers into the spotlight.
25 Jul, 10:01 — 25 Jul, 10:01
Sources
Showing 1 of 1 sources
An FDA panel has narrowly voted to back four peptides, bringing the stock of companies like Hims & Hers into the spotlight.
